We build relationships, not just contracts.
Drug Discovery is one of the most important components for the pharmaceutical drug research and development continuum to realize promising therapeutics for tomorrow. By working with Drug Discovery Alliances, you and your team will be able to leverage CRO’s in our network who have been key players in the pharmaceutical drug discovery industry for decades by helping to bring valuable medicinal chemistry leads into the pipeline. A number of these promising candidates have gone on to be commercialized drugs. By working with DDA, we will help you to identify the drug discovery CRO that will be the best fit to help you achieve your goals to fill your pipeline with the highest quality leads supporting your drug discovery programs.
CEO at Drug Discovery Alliances
Deborah has decades of business development experience marketing contract services, drug licensing and new technologies to the pharmaceutical industry. She founded Drug Discovery Alliances, Inc. in 2001 to connect pharmaceutical and biotech companies with top industry contractors who facilitate and speed projects. Deborah earned a Ph.D. in Medicinal Chemistry from University of North Carolina, Chapel Hill and has worked as an organic chemist for Rhone Poulenc. She subsequently worked for Accelyrs and MDL, marketing molecular modeling technologies and databases including Beilstein and Crossfire to the pharmaceutical industry.
Latest posts by Deborah Minor (see all)
- Drug Discovery Alliances at CPHI Barcelona 2023! - October 6, 2023
- Enhancing Resilience in Pharmaceutical Supply Chains with Drug Discovery Alliances - September 4, 2023
- Igniting Innovation through Supplier Diversity: Collaborate with Drug Discovery Alliances at Chemoutsourcing 2023! - August 14, 2023